Pilot study on efficacy and safety of bilastine in preventing angioedema attacks in patients with recurrent angioedema of unkown etiology (idiopatic angioedema, rIAE)

Trial Profile

Pilot study on efficacy and safety of bilastine in preventing angioedema attacks in patients with recurrent angioedema of unkown etiology (idiopatic angioedema, rIAE)

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 Jul 2014

At a glance

  • Drugs Bilastine (Primary)
  • Indications Angioedema
  • Focus Therapeutic Use
  • Acronyms Right
  • Sponsors Menarini
  • Most Recent Events

    • 14 Jun 2014 According to the European Clinical Trials Database record, status changed from completed to discontinued.
    • 07 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top